Arax Advisory Partners’s Larimar Therapeutics LRMR Stock Holding History

Arax Advisory Partners’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$707	Buy	157 +147	+1,470%	+$588	﹤0.01%	3359
2025 Q4	$38	Sell	10 -10,915	-100%	-$42.5K	﹤0.01%	3963
2025 Q3	$35.3K	Buy	+10,925	New	+$41K	﹤0.01%	2006
2025 Q1	–	Sell	-405	Closed	-$1.57K	–	2891
2024 Q4	$1.57K	Buy	405 +119	+42%	+$786	﹤0.01%	2064
2024 Q3	$1.87K	Hold	286	–	–	﹤0.01%	2088
2024 Q2	$2.07K	Buy	+286	New	+$2.19K	﹤0.01%	1952

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return